Clinical Trial Update: Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing eribulin in combination with radiation therapy for patients with surgically resectable retroperitoneal liposarcoma; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liposarcoma
• Retroperitoneal Liposarcoma

Drugs mentioned

• Eribulin (eribulin mesilate)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Liposarcoma, Malignant Abdominal Neoplasm | Phase 1 | Status: ACTIVE_NOT_RECRUITING